A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Clinical trial NCT06045689 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06045689
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2023-10-05
Primary completion: 2025-10-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.